SAMHSA's final rule makes COVID-era flexibilities permanent for opioid treatment programs
Fierce Healthcare
FEBRUARY 6, 2024
Several COVID-era flexibilities relied upon by opioid treatment programs and their hundreds of thousands of patients will become permanent later this year, the Substance Abuse and Mental Healt | The final rule allows some providers to prescribe medication for opioid use disorder like buprenorphine via telehealth without an initial in-person exam.
Let's personalize your content